Biopharma and med-tech company deals and M&As: Abbott, Alvotech, Ambros, Amplitude, Avricore, Beyond Air, Bioarctic, BMS, Chai Discovery, Chong Kun Dang, Darmiyan ...
Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.
Product Categories ...
Despite Vertex Pharmaceuticals Inc.’s mostly positive phase III study results of a non-opioid for treating moderate to severe acute pain, the data for a key secondary endpoint show VX-548 is not as ...
In a deal worth $1.32 billion, Jazz Pharmaceuticals plc made plans to acquire Actio Biosciences Inc. and its lead epilepsy drug ABS-1230 earlier this month, ...
A compound targeting serotonin receptor 5-HT2A (5-HT2AR) signaling in the gut could activate antitumor immunity in colorectal cancer (CRC) and improve responses to immunotherapy without causing ...
The emerging field of cancer neuroscience is plotting out the ways in which the nervous system and tumors communicate and pointing to potential drug targets that could modulate the neuro-cancer ...
The scientific community continues to make progress at uncovering the elements that could lead to a cure for HIV. The virus remains latent in reservoirs that are difficult to eliminate, so researchers ...
Infinimmune Inc. raised $75 million in a series A round, co-led by Regeneron Ventures and Playground Global, to advance its IL-22-targeted IFX-101 and IL-13-targeted IFX-201 into the clinic in 2027 ...
Remedium Bio Inc. has announced the initial closing of its planned $10 million series A financing as it advances its durable protein therapeutics platform toward first-in-human development.
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have disclosed sodium channel protein type 8 subunit α (SCN8A; Nav1.6) blockers reported to be useful for the ...
Gilead Sciences Inc. has exercised its option to obtain an exclusive license for a preclinical bispecific program under its 2022 collaboration agreement with Macrogenics Inc., triggering a $10 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results